Corvus Pharmaceuticals
CRVS
#6513
Rank
NZ$1.49 B
Marketcap
NZ$17.68
Share price
-3.40%
Change (1 day)
15.82%
Change (1 year)

EPS for Corvus Pharmaceuticals (CRVS)

EPS in 2026 (TTM): NZ-$1.06

According to Corvus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$1.12. In 2025 the company made an earnings per share (EPS) of NZ-$0.29 an increase over its 2024 EPS that were of NZ-$1.77.

EPS history for Corvus Pharmaceuticals from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$1.06262.9%
2025NZ-$0.29-83.51%
2024NZ-$1.77
2022NZ-$1.63-16.04%
2021NZ-$1.94404.76%
2020NZ-$0.38-86.79%
2019NZ-$2.91-9.14%
2018NZ-$3.20-35.66%
2017NZ-$4.97-60.47%
2016NZ-$12.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.47 121.31%๐Ÿ‡บ๐Ÿ‡ธ USA